Clinical Trial

Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence

Study acronym: CASPR
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated January 23, 2025 (before its estimated May 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a multi-center retrospective analysis of consecutive adult patients with cryptogenic stroke patients following a comprehensive workup for the underlying stroke etiology. Patients will be eligible for inclusion if the index stroke event occurred between 1/1/2016 and 06/30/2022.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-04-30; most recent amendment 2025-01-21.
Trial Details
NCT Number NCT06398366
Lead Sponsor The Cooper Health System
Collaborators: Duke University, Covenant Health, Canada, University of Colorado, Denver, Medical University of South Carolina, University of Maryland, Baltimore, University of Pennsylvania, Emory University, University of Chicago, University of Tennessee, Ohio State University, West Virginia University, Mayo Clinic, Boston Medical Center, Rhode Island Hospital, Beth Israel Lahey Health, Christiana Care Health Services, Henry Ford Health System, Thomas Jefferson University, University of Iowa, University of California, Los Angeles, Allina Health System, Yale University, The University of Texas Health Science Center, Houston, Dartmouth-Hitchcock Medical Center, Virginia Commonwealth University
Conditions Cryptogenic Stroke
Enrollment 2,000 participants
Start Date 2022-09-14
Primary Completion 2025-05-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-23